| Q49238945 | 1,25-Dihydroxy vitamin D3 stimulates system A amino acid transport in primary human trophoblast cells |
| Q61485024 | A bioinformatics workflow to decipher transcriptomic data from vitamin D studies |
| Q47848180 | An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis |
| Q26768528 | Antibody Targeting of "Steady-State" Dendritic Cells Induces Tolerance Mediated by Regulatory T Cells |
| Q50536560 | Blockade of Host β2-Adrenergic Receptor Enhances Graft-versus-Tumor Effect through Modulating APCs. |
| Q47142681 | Butyrate Conditions Human Dendritic Cells to Prime Type 1 Regulatory T Cells via both Histone Deacetylase Inhibition and G Protein-Coupled Receptor 109A Signaling |
| Q64235971 | Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account? |
| Q26738964 | Chronic over-nutrition and dysregulation of GSK3 in diseases |
| Q26773299 | Clinical Use of Tolerogenic Dendritic Cells-Harmonization Approach in European Collaborative Effort |
| Q57296139 | Comparative transcriptomic profile of tolerogenic dendritic cells differentiated with vitamin D3, dexamethasone and rapamycin |
| Q52576096 | De Novo Fatty Acid Synthesis During Mycobacterial Infection Is a Prerequisite for the Function of Highly Proliferative T Cells, But Not for Dendritic Cells or Macrophages. |
| Q33800615 | Dendritic cells, engineered to overexpress 25-hydroxyvitamin D 1α-hydroxylase and pulsed with a myelin antigen, provide myelin-specific suppression of ongoing experimental allergic encephalomyelitis |
| Q46267369 | Dexamethasone and Monophosphoryl Lipid A Induce a Distinctive Profile on Monocyte-Derived Dendritic Cells through Transcriptional Modulation of Genes Associated With Essential Processes of the Immune Response |
| Q47571105 | Differential transcriptome of tolerogenic versus inflammatory dendritic cells points to modulated T1D genetic risk and enriched immune regulation |
| Q42516076 | Differentiation of human dendritic cell subsets for immune tolerance induction |
| Q97519058 | FTY720 Regulates Mitochondria Biogenesis in Dendritic Cells to Prevent Kidney Ischemic Reperfusion Injury |
| Q38739103 | Frequency of Dendritic Cells and Their Expression of Costimulatory Molecules in Children with Autism Spectrum Disorders. |
| Q26779413 | Gene Expression Profiling of Human Monocyte-derived Dendritic Cells - Searching for Molecular Regulators of Tolerogenicity |
| Q33766590 | Glucose represses dendritic cell-induced T cell responses |
| Q99711558 | Human Regulatory Dendritic Cells Develop From Monocytes in Response to Signals From Regulatory and Helper T Cells |
| Q26773266 | Immunometabolism governs dendritic cell and macrophage function |
| Q61455241 | Immunomodulatory Effect of Vitamin D and Its Potential Role in the Prevention and Treatment of Type 1 Diabetes Mellitus-A Narrative Review |
| Q58707479 | Induction of Tolerogenic Dendritic Cells by Endogenous Biomolecules: An Update |
| Q59359548 | Infection with the dengue RNA virus activates TLR9 signaling in human dendritic cells |
| Q52564079 | Inflammatory Bowel Disease and Immunonutrition: Novel Therapeutic Approaches Through Modulation of Diet and the Gut Microbiome. |
| Q90079848 | Influence of Vitamin D on Islet Autoimmunity and Beta-Cell Function in Type 1 Diabetes |
| Q50217779 | Innate and Adaptive Immune Cell Metabolism in Tumor Microenvironment |
| Q92802463 | LKB1 expressed in dendritic cells governs the development and expansion of thymus-derived regulatory T cells |
| Q89419142 | Local exchange of metabolites shapes immunity |
| Q91782476 | MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients |
| Q36084601 | Mapping Variation in Cellular and Transcriptional Response to 1,25-Dihydroxyvitamin D3 in Peripheral Blood Mononuclear Cells |
| Q64088355 | Metabolic Control of Dendritic Cell Functions: Digesting Information |
| Q39030292 | Metabolites: deciphering the molecular language between DCs and their environment. |
| Q39410087 | Mitochondrial control of immunity: beyond ATP. |
| Q42747099 | NF-κB, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment |
| Q37599437 | Narrowband UVB Phototherapy for Clinically Isolated Syndrome: A Trial to Deliver the Benefits of Vitamin D and Other UVB-Induced Molecules |
| Q89209641 | Nuclear receptor expression atlas in BMDCs: Nr4a2 restricts immunogenicity of BMDCs and impedes EAE |
| Q47321673 | Pathway analysis of transcriptomic data shows immunometabolic effects of vitamin D. |
| Q36867923 | Patterns of Transcriptional Response to 1,25-Dihydroxyvitamin D3 and Bacterial Lipopolysaccharide in Primary Human Monocytes |
| Q61448748 | Regulation of Dendritic Cell Immune Function and Metabolism by Cellular Nutrient Sensor Mammalian Target of Rapamycin (mTOR) |
| Q38592317 | Regulation of innate immune cell function by mTOR. |
| Q26779405 | Role of Dendritic Cells in the Induction of Lymphocyte Tolerance |
| Q92243921 | STAT3 Activation in Combination with NF-KappaB Inhibition Induces Tolerogenic Dendritic Cells with High Therapeutic Potential to Attenuate Collagen-Induced Arthritis |
| Q57300168 | Searching for the Transcriptomic Signature of Immune Tolerance Induction-Biomarkers of Safety and Functionality for Tolerogenic Dendritic Cells and Regulatory Macrophages |
| Q57470854 | Skeletal and extra-skeletal actions of vitamin D: Current evidence and outstanding questions |
| Q91670582 | Synergistic Effects of Interferon-γ and Vitamin D3 Signaling in Induction of ILT-3highPDL-1high Tolerogenic Dendritic Cells |
| Q27702245 | T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex |
| Q59327151 | The Isoform Selective Roles of PI3Ks in Dendritic Cell Biology and Function |
| Q49242675 | Tolerance through Education: How Tolerogenic Dendritic Cells Shape Immunity. |
| Q47128789 | Translating Mechanism of Regulatory Action of Tolerogenic Dendritic Cells to Monitoring Endpoints in Clinical Trials |
| Q49376559 | Trichinella spiralis Excretory-Secretory Products Induce Tolerogenic Properties in Human Dendritic Cells via Toll-Like Receptors 2 and 4. |
| Q45071253 | Vitamin D Receptor Signaling and Cancer |
| Q26784321 | Vitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirin |
| Q46921354 | Vitamin D as a Novel Regulator of Tumor Metabolism: Insights on Potential Mechanisms and Implications for Anti-Cancer Therapy |
| Q38797005 | Vitamin D immunoregulation through dendritic cells |
| Q34550631 | Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. |
| Q49985993 | Vitamin D receptor: A novel therapeutic target for kidney diseases |
| Q34621641 | Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. |
| Q38951050 | mTOR-Mediated Regulation of Dendritic Cell Differentiation and Function |
Search more.